Authors


Tricia Wilms Twaranovica, MS, RN, OCN

Latest:

Do You Use Nurses in Your Specialty Pharmacy? You May Want To

Nurses can educate patients and caregivers regarding disease states and the specialty medications prescribed for them. 



Feride H. Frech-Tamas, MPH, RPh

Latest:

Value-Based Benefit Design and Healthcare Utilization in Asthma, Hypertension, and Diabetes

A value-based benefit design program for prescription medications for asthma, hypertension, and diabetes could result in increased prescription use and decreased healthcare utilization and costs.


David P. Chinitz, PhD

Latest:

Presenting Prescribing Data to Primary Care Physicians to Explain Nonadherence to Acute Cystitis Treatment Guidelines

Nominal group technique reinforced with electronic voting technology to stimulate conversation is a feasible technique for conducting focus groups with primary care physicians.


Robert W. Dubois, MD, PhD

Latest:

How Can We Address Barriers to Accessing Needed Care?

Adherence and access to higher-value care can make a big difference in reducing costs for patients and our healthcare system; however, the financial burden of high-deductible health plans and out-of-pocket costs must also be considered.


Gabrielle Bennett

Latest:

The Budgetary Impact of Promising Prostate Cancer Drugs

With recent therapeutic advances, the treatment landscape for metastatic castration-resistant prostate cancer is changing rapidly.


Bruce Roberts, RPh

Latest:

WELCOME TO INDEPENDENT PHARMACY

Mr. Roberts is the executive vice president and chief executive officer of the National Community Pharmacists Association.



Donna Feudo, BSPharm, RPh

Latest:

New Jersey Pharmacists' Perceptions of the New Jersey Prescription Monitoring Program

With prescription opioid overdoses leading to more deaths in the United States each year than cocaine and heroin combined, prescription drug abuse, misuse, and diversion have become growing concerns.



Rajiv Shah, MD

Latest:

Patients with Advanced Cancer: Update on Pain Management

Despite advances in pain management and palliative care, intractable cancer pain remains a significant clinical, social, and financial burden in treating the oncologic population.


Amanda Tracy, PharmD Candidate

Latest:

Advocating for Patients with Diabetic Nephropathy

Although no cure exists, pharmacologic and nonpharmacologic measures can help patients prevent onset or progression of diabetic nephropathy to preserve kidney function.


Jamie Kirkwood

Latest:

City of New Orleans Employees: Building a Healthier Future in Wake of Katrina

New Orleans has implemented an Asheville-like disease state management model with the help of the APhA Foundation's HealthMapRx program.


Greta Pelegrin, PharmD

Latest:

Understanding Alzheimer's

In the early stages, AD causes loss of memory and changes in emotions. In the late stages, however, care of patients becomes more complex and help is needed.


Sarah McBane, PharmD, CDE, BCPS, FCCP

Latest:

Scheduling Good Health: Pharmacists as Primary Immunizers

Pharmacists can play an important role in improving immunization rates.




Khyati Patel, PharmD, BCACP

Latest:

Pharmacy and Telehealth: An Interprofessional Model at a Student-led Free Clinic

Unique model demonstrates how clinical pharmacy services could be integrated into an interprofessional telehealth clinic.


Shelby Leheny, PharmD Candidate 2017

Latest:

4 Complementary and Alternative Medicines for the Flu

Influenza is a highly contagious viral infection that affects the respiratory passages causing symptoms such as fever, severe aching, running nose, and cough. According to the CDC, the flu viruses spread mainly by droplets dispersing when flu-infected patients cough, talk, or sneeze.


Kate Gamble, Senior Editor

Latest:

Protecting Against Pharmacy Crime

Pharmacy robberies and burglaries are on the rise. What can pharmacists do to protect themselves and their stores?


Rebecca Elizabeth Norwalt, PharmD Candidate

Latest:

Secondary Smoke Is Dangerous to Asthmatic Children

Ms. Norwalt is a 2008 PharmD candidate and Dr. Isaac is a clinical assistant professor of pharmacy at Xavier University of Louisiana College of Pharmacy, New Orleans.


R. Scott Leslie, MPH, PhD

Latest:

E-Prescribing With Decision Support Is Associated With Improvements in Medication Adherence

This study evaluates whether provider adoption and use of formulary decision support for e-prescribing are directly associated with significant prescriber and patient behavior change.


Armando Bardisa, PharmD, CPh

Latest:

Ten Tips to Help Your Patients Increase Fertility Naturally

How specialty pharmacies can improve the treatment success of women receiving in-vitro fertilization.


Jim Burke

Latest:

Financial Accruals in the Specialty Pharmaceutical Industry: The Case for Automating the Process

As payers and providers are required to provide real-world outcomes data, there is high demand for the detailed financial reporting that an automated financial accruals process can produce. Here's what stakeholders need to know about the process.


Laura Panjwani, OncLive

Latest:

The Changing Landscape of Breast Cancer Treatment

Several chemotherapy agents have been investigated for neoadjuvant use in HER2-positive breast cancer.



Marie A. Smith, PharmD

Latest:

Catalyzing Change: Educating Healthcare Stakeholders on Pharmacist Care Programs

A multistakeholder, statewide symposium demonstrated the value of innovative pharmacist-led patient care programs and generated 9 key measures for planning or examining such programs.


Carol A. Ott, PharmD, BCPP

Latest:

Mental Health First Aid as a Skill Set for Community Pharmacy Personnel

Mental illness affects tens of millions of people in the United States each year. However, overall, only about half of those affected receive treatment.


Khalid Eljaaly, PharmD, MS, BCPS

Latest:

Community-Acquired Pneumonia: Opportunities for Generalist Stewardship Pharmacists

Community-acquired pneumonia is a common infection and a leading cause of morbidity and mortality worldwide.


Christopher R. Frei, PharmD, MS

Latest:

Cost of Squamous Cell Cancer of the Head and Neck

The cost of squamous cell cancer of the head and neck is driven primarily by the end-of-life phase. Treatment costs increased following the approval of cetuximab.